DHR — Danaher Corporation (Stock)

Price: $231.5 · 1 day: +3.03% · 5 days: +6.46% · 1 month: +10.58% · YTD: +1.13%
As of 2026-10-15 20:00 UTC.

52-week range: $160.93 – $242.8 (currently at 86% of the range).

The brief

DHR is in an uptrend, momentum firm. $242.05 is the level overhead; $225 the first support below.

6 of 6 technical checks lean bullish.

• Price vs 50-day: above
• Price vs 200-day: above
• 50d vs 200d avg: above
• MACD: bullish
• RSI momentum: 57
• 5-day tape: +6.5%

Key levels

Indicators

Next earnings: 2026-10-21.

Latest DHR news

• DANAHER CORP /DE/ — Form 8-K: 5.02 Departure/Election of Directors or Officers; 8.01 Other Events — ```json { "summary": "Danaher Corp filed an 8-K on October 13, 2026, disclosing changes related to its board of directors or executive officers under Item 5.02, along with other material events under Item 8.01. The fil (SEC EDGAR, 2026-10-13)
• Perimeter Medical Imaging AI Appoints Finance Executive Michelle Caron to Board of Directors — Perimeter Medical Imaging AI, Inc. (TSX-V: PINK) (OTCQX: PYNKF) announced the immediate appointment of Michelle Caron, CPA, to its Board of Directors. Caron currently serves as CFO of Nasdaq-listed A10 Networks and previ (PR Newswire, 2026-10-02)
• Masimo Wins Two OCTANE High Tech Awards - Company Recognized for 'Deal of the Year' and 'Best Technology Leadership Team' — Masimo, a Danaher company specializing in patient monitoring solutions, received two honors at the 2026 Octane High Tech Awards: Deal of the Year and Best Technology Company Leadership Team. The Deal of the Year award re (PR Newswire, 2026-09-30)
• Cepheid Receives FDA Clearance for Xpert® Respiratory Panel to Aid in the Diagnosis of Respiratory Tract Infection — Cepheid, a Danaher company, received FDA clearance for its Xpert Respiratory Panel, a multiplex PCR test that detects 13 common viral and bacterial respiratory pathogens from a single nasopharyngeal swab. The test is des (PR Newswire, 2026-09-29)
• Microfluidics Market to Reach US$ 43 Bn by 2031, Growing at 9.8% CAGR as Point-of-Care and Organ-on-Chip Adoption Expands: New Report by Wissen Research — The global microfluidics market is projected to grow from USD 26.9 billion in 2026 to USD 43 billion by 2031, at a CAGR of 9.8%, according to Wissen Research. Growth is driven by rising demand for point-of-care diagnosti (PR Newswire, 2026-09-28)
• Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients — Leica Biosystems, a Danaher subsidiary, announced the completion of its acquisition of StatLab Medical Products, a private provider of pre-analytical consumables and equipment, from Linden Capital Partners and Audax Priv (PR Newswire, 2026-09-28)
• Liquid Handling System Market worth $7.79 billion by 2031 - Exclusive Report by MarketsandMarkets™ — MarketsandMarkets projects the global liquid handling system market will grow from USD 5.26 billion in 2026 to USD 7.79 billion by 2031, representing a compound annual growth rate (CAGR) of 8.2%. The automated systems se (PR Newswire, 2026-09-25)
• Forbes 250: America's Most Successful Living Builders — Forbes released its Forbes 250 list recognizing America's greatest builders across business, infrastructure, and innovation sectors. The ranking includes prominent figures such as Jeff Bezos (Amazon, $717 billion revenue (Forbes, 2026-09-24)

Explore more

Interactive DHR chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs